Literature DB >> 22843766

Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.

Ka Kit Wong1, David M Raffel, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen, Sid Gilman.   

Abstract

PURPOSE: To determine whether cardiac sympathetic denervation in idiopathic Parkinson disease (IPD) affects the left ventricle in a distinct regional pattern versus a more global pattern with use of carbon 11 (11C) meta-hydroxyephedrine (HED) positron emission tomography (PET).
MATERIALS AND METHODS: This prospective study was approved by the institutional review board and was compliant with HIPAA. Informed consent was obtained from all subjects. Cardiac PET was performed with 11C HED in 27 patients with IPD (20 men and seven women aged 50-74 years; mean age, 62 years±6 [standard deviation]). 11C HED retention indexes (RIs), which reflect nerve density and integrity, were determined. RIs for 33 healthy control subjects (15 men and 18 women aged 20-78 years; mean age, 47 years±17) were used as a control database. Patients with IPD were compared with control subjects by using z score analysis. Global and segmental measurements of sympathetic denervation were expressed as percentage extent, z score severity, and severity-extent product (SEP). Group comparisons were performed with the Student t test.
RESULTS: The mean 11C HED RI was 0.086 mL of blood per minute per milliliter tissue±0.015 for control subjects and 0.043 mL of blood per minute per milliliter tissue±0.016 for patients with IPD (P<0001). When compared with normative data from the control database, profound cardiac denervation (global extent>50%) was seen in most patients (19 of 27 patients, 70%). Four patients had normal 11C HED studies and four had mild denervation (global extent<25%). The mean global denervation extent was 62%±38, the mean severity z score was -2.7±1.2, and the mean SEP was -202±131 (range, -358 to 0). Segmental analysis revealed relative sparing of anterior and proximal septal segments (mean extent, 48%-51%; mean severity z score, -2.47 to -2.0; mean SEP, -167 to -139), with lateral and proximal inferior segments more severely affected (mean extent, 68%-73%; mean severity z score, -2.8 to -2.62; mean SEP, -271 to -230). Patients with normal findings or preserved denervation did not significantly differ in mean age (t=1.09) or disease duration (t=0.44) compared to patients with severe sympathetic denervation.
CONCLUSION: Cardiac sympathetic denervation in IPD is extensive, with a segmental pattern that involves the proximal lateral left ventricular wall most severely, with relative sparing of the anterior and proximal septal walls. © RSNA, 2012.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843766      PMCID: PMC3447171          DOI: 10.1148/radiol.12112723

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  44 in total

1.  Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.

Authors:  R A Koeppe; K A Frey; D E Kuhl; M R Kilbourn
Journal:  J Cereb Blood Flow Metab       Date:  1999-12       Impact factor: 6.200

2.  Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.

Authors:  Phil Hyu Lee; Seung Hyeon Yeo; Hyun Joon Kim; Hyo Young Youm
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

3.  Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.

Authors:  Joong-Seok Kim; Phil-Hyu Lee; Kwang-Soo Lee; Jeong-Wook Park; Yeong-In Kim; Yong-An Chung; Sung-Hoon Kim; Seung-Hyun Kim; Juhan Kim; Yun-Young Choi; Hee-Tae Kim
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

4.  Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.

Authors:  H Takatsu; H Nishida; H Matsuo; S Watanabe; K Nagashima; H Wada; T Noda; K Nishigaki; H Fujiwara
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

5.  Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.

Authors:  A Druschky; M J Hilz; G Platsch; M Radespiel-Tröger; K Druschky; T Kuwert; B Neundörfer
Journal:  J Neurol Sci       Date:  2000-04-01       Impact factor: 3.181

Review 6.  Cardiac autonomic neuropathy in diabetes: a clinical perspective.

Authors:  Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

7.  Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.

Authors:  Satoshi Orimo; Toshiki Uchihara; Ayako Nakamura; Fumiaki Mori; Akiyoshi Kakita; Koichi Wakabayashi; Hitoshi Takahashi
Journal:  Brain       Date:  2007-12-13       Impact factor: 13.501

8.  Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.

Authors:  Michio Kitayama; Kenji Wada-Isoe; Yoshito Irizawa; Kenji Nakashima
Journal:  J Neurol Sci       Date:  2007-08-15       Impact factor: 3.181

9.  Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms.

Authors:  Joong-Seok Kim; Kwang-Soo Lee; In-Uk Song; Yeong-In Kim; Sung-Hoon Kim; I-Ryung You; Hee-Tae Kim
Journal:  J Neurol Sci       Date:  2008-04-18       Impact factor: 3.181

10.  Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.

Authors:  Jörg Spiegel; Dirk Hellwig; Georgios Farmakis; Wolfgang H Jost; Samuel Samnick; Klaus Fassbender; Carl-Martin Kirsch; Ulrich Dillmann
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

View more
  16 in total

1.  Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease.

Authors:  Jin-Kyoung Oh; Eun-Kyoung Choi; In-Uk Song; Joong-Seok Kim; Yong-An Chung
Journal:  J Neural Transm (Vienna)       Date:  2015-05-24       Impact factor: 3.575

Review 2.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

Review 3.  Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Martijn L T M Müller
Journal:  Int Rev Neurobiol       Date:  2018-09-20       Impact factor: 3.230

4.  Post mortem evaluation of inflammation, oxidative stress, and PPARγ activation in a nonhuman primate model of cardiac sympathetic neurodegeneration.

Authors:  Jeanette M Metzger; Helen N Matsoff; Alexandra D Zinnen; Rachel A Fleddermann; Viktoriya Bondarenko; Heather A Simmons; Andres Mejia; Colleen F Moore; Marina E Emborg
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

5.  2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET.

Authors:  Ka Kit Wong; David M Raffel; Nicolaas I Bohnen; Gulcin Altinok; Sid Gilman; Kirk A Frey
Journal:  J Nucl Med       Date:  2016-08-18       Impact factor: 10.057

Review 6.  Vesicular integrity in Parkinson's disease.

Authors:  Shawn P Alter; Gina M Lenzi; Alison I Bernstein; Gary W Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

Review 7.  Roles of cardiac sympathetic neuroimaging in autonomic medicine.

Authors:  David S Goldstein; William P Cheshire
Journal:  Clin Auton Res       Date:  2018-07-30       Impact factor: 4.435

8.  Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients.

Authors:  Harish Goyal; Anshul Sharma; Chetan Patel; K K Deepak; Madhavi Tripathi; Priyanka Gupta; Rajeev Kumar; Chandra Shekhar Bal; Vinay Goyal
Journal:  J Nucl Cardiol       Date:  2021-01-10       Impact factor: 3.872

9.  Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.

Authors:  Valerie Joers; Kristine Dilley; Shahrose Rahman; Corinne Jones; Jeanette Shultz; Heather Simmons; Marina E Emborg
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

10.  In vivo imaging of inflammation and oxidative stress in a nonhuman primate model of cardiac sympathetic neurodegeneration.

Authors:  Jeanette M Metzger; Colleen F Moore; Carissa A Boettcher; Kevin G Brunner; Rachel A Fleddermann; Helen N Matsoff; Henry A Resnikoff; Viktoriya Bondarenko; Timothy J Kamp; Timothy A Hacker; Todd E Barnhart; Patrick J Lao; Bradley T Christian; R Jerry Nickles; Catherine L Gallagher; James E Holden; Marina E Emborg
Journal:  NPJ Parkinsons Dis       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.